2 recruiting. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Recruiting 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow FIGO Stage IV Ovarian Cancer 2014: new trials by email Literature Review of FIGO Stage IV Ovarian Cancer 2014 trials Research Report on FIGO Stage IV Ovarian Cancer 2014
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer Bevacizumab, Biospecimen Collection, Computed Tomography - Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma | Phase 3 | Recruiting | NRG Oncology | 880 | 2025-03-12 | 2026-08-07 |
| Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial Biopsy, Biospecimen Collection, Computed Tomography - Advanced Fallopian Tube Carcinoma, Advanced Fallopian Tube High Grade Serous Adenocarcinoma | Phase 2 | Recruiting | Mayo Clinic | 78 | 2024-11-12 | 2026-10-02 |
Neoplasms (1) · Ovarian Neoplasms (1)
Adnexal Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gonadal Disorders (1) · Neoplasms by Site (1) · Ovarian Diseases (1) · Urogenital Diseases (1) · Urogenital Neoplasms (1)
Magnetic Resonance Spectroscopy (2) · Specimen Handling (2) · Bevacizumab (1) · Biopsy (1) · Diphtheria Toxoid (1) · Diphtheria-Tetanus Vaccine (1) · Diphtheria-Tetanus-acellular Pertussis Vaccines (1) · Disulfides (1) · Immunoglobulin G (1) · Leukapheresis (1) · Tetanus Toxoid (1) · adacel (1) · olaparib (1)
Mayo Clinic (1) · NRG Oncology (1)
United States (2) · Japan (1) · Puerto Rico (1)
Matthew S. Block, MD, PhD (1) · Ying Liu (1)
U10CA180868 (1)